Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 SUMMARY Cells Expressing Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 provides in depth analysis...

April 2021 30 pages

Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC...

April 2021 30 pages

Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 SUMMARY Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD...

April 2021 35 pages

Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Drugs in Development, 2021 SUMMARY Cells Expressing Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD...

April 2021 30 pages

Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 13 Receptor Subunit Al...

April 2021 45 pages

Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p...

April 2021 35 pages

Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Development, 2021 SUMMARY Cells Expressing Interleukin 3 Receptor Subunit Alpha (CD123 or IL3RA) - Drugs in Developmen...

April 2021 85 pages

Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021 SUMMARY Cells Expressing Latent Membrane Protein 1 (Protein p63 or LMP1) - Drugs in Development, 2021 prov...

April 2021 35 pages

Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development, 2021 SUMMARY Cells Expressing Latent Membrane Protein 2 (Terminal Protein or LMP2) - Drugs in Development,...

April 2021 35 pages

Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021 SUMMARY Cells Expressing Leukocyte Antigen CD37 (Tetraspanin 26 or CD37) - Drugs in Development, 2021 prov...

April 2021 35 pages

Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or p145 c Kit or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protei...

April 2021 35 pages

Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially Expressed Antigen Of Melanoma or PRAME) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Antigen Preferentially Expressed In Tumors (Cancer/Testis Antigen 130 or Opa Interacting Protein 4 or OIP4 or Preferentially Expressed Antigen Of Melanoma or PRAME) - Drugs i...

April 2021 35 pages

Cells Expressing Melanoma Antigen Recognized By T Cells 1 (Protein Melan A or Antigen SK29 AA or Antigen LB39 AA or MART1 or MLANA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Antigen Recognized By T Cells 1 (Protein Melan A or Antigen SK29 AA or Antigen LB39 AA or MART1 or MLANA) - Drugs in Development, 2021 SUMMARY Cells Expressing Melanoma Antig...

April 2021 30 pages

Cells Expressing Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021 SUMMARY Cells Expressing Melanoma Associated Antigen...

April 2021 35 pages

Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021 SUMMARY Cells Expressing Melan...

April 2021 45 pages

Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 SUMMARY Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte...

April 2021 110 pages

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 SUMMARY Cells Expressing Mucin 16 (Ovarian Cancer Related...

April 2021 35 pages

Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Myeloid Cell Surface Antigen CD33 (Sialic Acid Binding Ig Like Lectin 3 or gp67 or CD33) - Drugs in Development, 2021 SUMMARY Cells Expressing Myeloid Cell Surface Antigen CD33 (Siali...

April 2021 90 pages

Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021 SUMMARY Cells Expressing Neural Cell Adhesion Molecule...

April 2021 35 pages

Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021 SUMMARY Cells Expressing Neural Cell Adhesion Molecule L1 (CD171 or L1CAM) - Drugs in Development, 2021...

April 2021 30 pages

Cells Expressing Phosphatidylserine - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Phosphatidylserine - Drugs in Development, 2021 SUMMARY Cells Expressing Phosphatidylserine - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Phosphatidylser...

April 2021 35 pages

Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021 SUMMARY Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD27...

April 2021 55 pages

Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Development, 2021 SUMMARY Cells Expressing Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Drugs in Develo...

April 2021 40 pages

Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or CD133 or PROM1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or CD133 or PROM1) - Drugs in Development, 2021 SUMMARY Cells Expressing Prominin 1 (Antigen AC133 or Prominin Like Protein 1 or C...

April 2021 35 pages

Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021 SUMMARY Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021 provides in depth analysis on Ce...

April 2021 35 pages

Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021 SUMMARY Cells Expressing Somatostatin Receptor (SSTR) - Drugs in Development, 2021 provides in depth analysis on Cells Expres...

April 2021 30 pages

Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 SUMMARY Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 provides...

April 2021 35 pages

Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021 SUMMARY Cells Expressing Syndecan 1 (CD138 or SDC1) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing...

April 2021 40 pages

Cells Expressing T Cell Antigen CD7 (GP40 or T Cell Leukemia Antigen or T Cell Surface Antigen Leu 9 or TP41 or CD7) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Antigen CD7 (GP40 or T Cell Leukemia Antigen or T Cell Surface Antigen Leu 9 or TP41 or CD7) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Antigen CD7 (GP40 or T...

April 2021 45 pages

Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen...

April 2021 30 pages

Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021 SUMMARY Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1...

April 2021 35 pages

Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021 SUMMARY Cells Expressing Tumor Associated Glycoprotein 72 (TAG72) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Cells Expressing Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or A...

April 2021 30 pages

Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021

US$ 3,000.00

Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 SUMMARY Cells Expressing Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 provides in depth analysis on Ce...

April 2021 65 pages

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021

US$ 3,000.00

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 SUMMARY Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprot...

April 2021 70 pages

Cellulitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Cellulitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cellulitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cellulitis pipeline landscape. The report...

April 2021 30 pages

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nerv...

April 2021 35 pages

Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 SUMMARY Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Central Reti...

April 2021 30 pages

Cerebral Edema (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cerebral Edema pipeline la...

April 2021 30 pages

Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cerebral (Fata...

April 2021 30 pages

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 provid...

April 2021 45 pages

Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 SUMMARY Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cerebrovascular Disease...

April 2021 35 pages

Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Charcot-Ma...

April 2021 40 pages

Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021 provides an overview...

April 2021 45 pages

Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021 provides an overview o...

April 2021 35 pages

Chemotherapy Effects (Toxicology) - Drugs in Development, 2021

US$ 2,000.00

Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemotherapy Effects pipeline landscap...

April 2021 90 pages

Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021

US$ 2,000.00

Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 30 pages

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 35 pages

Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021

US$ 2,000.00

Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 40 pages

Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Chem...

April 2021 35 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1